vs
GOLD RESOURCE CORP（GORO）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是GOLD RESOURCE CORP的1.4倍（$69.8M vs $51.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 35.1%，领先348.9%），GOLD RESOURCE CORP同比增速更快（295.5% vs 21.2%），过去两年GOLD RESOURCE CORP的营收复合增速更高（65.6% vs 53.7%）
黄金资源公司是一家总部位于加拿大温哥华的矿业企业，目前专注于开发位于美国犹他州与内华达州交界处的金泉金银矿。公司成立于2006年，目前分别在加拿大多伦多证券交易所和美国OTCQX市场挂牌上市，核心业务聚焦贵金属矿的勘探与开发。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
GORO vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$51.3M
营收增速更快
GORO
高出274.3%
21.2%
净利率更高
RIGL
高出348.9%
35.1%
两年增速更快
GORO
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $51.3M | $69.8M |
| 净利润 | $18.0M | $268.1M |
| 毛利率 | 51.5% | 91.5% |
| 营业利润率 | 38.9% | 33.2% |
| 净利率 | 35.1% | 384.0% |
| 营收同比 | 295.5% | 21.2% |
| 净利润同比 | 261.6% | 1769.2% |
| 每股收益（稀释后） | $0.14 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GORORIGL
| Q4 25 | $51.3M | $69.8M | ||
| Q3 25 | $24.9M | $69.5M | ||
| Q2 25 | $11.2M | $101.7M | ||
| Q1 25 | $12.4M | $53.3M | ||
| Q4 24 | $13.0M | $57.6M | ||
| Q3 24 | $13.3M | $55.3M | ||
| Q2 24 | $20.8M | $36.8M | ||
| Q1 24 | $18.7M | $29.5M |
净利润GORORIGL
| Q4 25 | $18.0M | $268.1M | ||
| Q3 25 | $-4.7M | $27.9M | ||
| Q2 25 | $-11.5M | $59.6M | ||
| Q1 25 | $-8.3M | $11.4M | ||
| Q4 24 | $-11.1M | $14.3M | ||
| Q3 24 | $-12.7M | $12.4M | ||
| Q2 24 | $-27.0M | $-1.0M | ||
| Q1 24 | $-5.7M | $-8.2M |
毛利率GORORIGL
| Q4 25 | 51.5% | 91.5% | ||
| Q3 25 | 25.0% | 93.2% | ||
| Q2 25 | -39.4% | 95.6% | ||
| Q1 25 | -11.8% | 91.7% | ||
| Q4 24 | -46.7% | 89.9% | ||
| Q3 24 | -65.3% | 85.5% | ||
| Q2 24 | -17.3% | 92.4% | ||
| Q1 24 | -11.6% | 93.1% |
营业利润率GORORIGL
| Q4 25 | 38.9% | 33.2% | ||
| Q3 25 | -14.9% | 40.9% | ||
| Q2 25 | -102.4% | 60.1% | ||
| Q1 25 | -63.1% | 23.9% | ||
| Q4 24 | -96.9% | 28.9% | ||
| Q3 24 | -122.7% | 25.4% | ||
| Q2 24 | -52.1% | 1.2% | ||
| Q1 24 | -40.4% | -23.6% |
净利率GORORIGL
| Q4 25 | 35.1% | 384.0% | ||
| Q3 25 | -18.7% | 40.2% | ||
| Q2 25 | -102.3% | 58.6% | ||
| Q1 25 | -67.3% | 21.5% | ||
| Q4 24 | -85.9% | 24.9% | ||
| Q3 24 | -95.5% | 22.5% | ||
| Q2 24 | -129.9% | -2.8% | ||
| Q1 24 | -30.4% | -27.9% |
每股收益（稀释后）GORORIGL
| Q4 25 | $0.14 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.09 | $3.28 | ||
| Q1 25 | $-0.07 | $0.63 | ||
| Q4 24 | $-0.11 | $0.82 | ||
| Q3 24 | $-0.14 | $0.70 | ||
| Q2 24 | $-0.30 | $-0.06 | ||
| Q1 24 | $-0.06 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $44.0M | $391.5M |
| 总资产 | $184.1M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资GORORIGL
| Q4 25 | $25.0M | $155.0M | ||
| Q3 25 | $9.8M | $137.1M | ||
| Q2 25 | $12.7M | $108.4M | ||
| Q1 25 | $4.9M | $77.1M | ||
| Q4 24 | $1.6M | $77.3M | ||
| Q3 24 | $1.4M | $61.1M | ||
| Q2 24 | $5.3M | $49.1M | ||
| Q1 24 | $5.7M | $49.5M |
总债务GORORIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益GORORIGL
| Q4 25 | $44.0M | $391.5M | ||
| Q3 25 | $26.0M | $117.6M | ||
| Q2 25 | $19.2M | $81.9M | ||
| Q1 25 | $24.6M | $18.6M | ||
| Q4 24 | $27.3M | $3.3M | ||
| Q3 24 | $37.9M | $-14.6M | ||
| Q2 24 | $49.8M | $-29.9M | ||
| Q1 24 | $74.9M | $-31.7M |
总资产GORORIGL
| Q4 25 | $184.1M | $513.6M | ||
| Q3 25 | $164.3M | $242.5M | ||
| Q2 25 | $155.1M | $206.7M | ||
| Q1 25 | $147.7M | $176.0M | ||
| Q4 24 | $145.9M | $164.0M | ||
| Q3 24 | $154.5M | $139.4M | ||
| Q2 24 | $161.5M | $128.4M | ||
| Q1 24 | $182.8M | $126.5M |
负债/权益比GORORIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $24.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $15.3M | — |
| 自由现金流率自由现金流/营收 | 29.8% | — |
| 资本支出强度资本支出/营收 | 17.3% | — |
| 现金转化率经营现金流/净利润 | 1.34× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $644.0K | — |
8季度趋势，按日历期对齐
经营现金流GORORIGL
| Q4 25 | $24.2M | $22.0M | ||
| Q3 25 | $-325.0K | $24.0M | ||
| Q2 25 | $-1.3M | $30.5M | ||
| Q1 25 | $-828.0K | $-893.0K | ||
| Q4 24 | $1.3M | $14.5M | ||
| Q3 24 | $-3.4M | $21.7M | ||
| Q2 24 | $-63.0K | $302.0K | ||
| Q1 24 | $1.5M | $-5.0M |
自由现金流GORORIGL
| Q4 25 | $15.3M | — | ||
| Q3 25 | $-7.8M | — | ||
| Q2 25 | $-3.8M | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | $58.0K | — | ||
| Q3 24 | $-5.7M | — | ||
| Q2 24 | $-2.1M | — | ||
| Q1 24 | $-512.0K | — |
自由现金流率GORORIGL
| Q4 25 | 29.8% | — | ||
| Q3 25 | -31.3% | — | ||
| Q2 25 | -34.2% | — | ||
| Q1 25 | -24.4% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -43.1% | — | ||
| Q2 24 | -10.0% | — | ||
| Q1 24 | -2.7% | — |
资本支出强度GORORIGL
| Q4 25 | 17.3% | — | ||
| Q3 25 | 30.0% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 17.7% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 9.7% | — | ||
| Q1 24 | 10.7% | — |
现金转化率GORORIGL
| Q4 25 | 1.34× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
